pharmafield logo - pharma news

Our way: Talent attraction specialist, Gemma Sawyer, reflects on a memorable 2016 for Novo...

    What makes Novo Nordisk different? Novo Nordisk is a unique company because we really care about our social, environmental and financial responsibility...
pharmafield logo - pharma news

Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS

  Human league: Global talent VP, Erica Briody, looks back on a fascinating 12 months for QuintilesIMS   What is QuintilesIMS and what makes...
pharmafield logo - pharma news

It has to be you: Looking for that promotion? Striving for success? Want an...

  Who is going to gain recognition, reward and achievement? Can you really leave it to someone or something else? Employment has changed. The...
pharmafield logo - pharma news

Transformers: connection, capabilities and culture in modern pharma

  Dan Masquelier, Partner, Cormis Partnership, talks about the importance of connection, capabilities and culture in a modern pharma ecosystem.   What is Cormis...
pharmafield logo - pharma news

Andrew Waiton explains why good habits start from the inside

KIE to success   Key Opinion Leaders, Thought Leaders and Key External Experts (KEE) have – for years – led best practice and influenced...
pharmafield logo - pharma news

Training your Millennials: How to measure the training investment in your Generation Y employees.

Historically, the paradigm has been that, ‘of course’ organisations should provide training for their employees. It engenders loyalty, and it is the socially responsible...

Latest articles

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust are continuing their innovative partnership to transform HIV patient care with the launch of...
Next stage of COVID-19 vaccination programme begins

Next stage of COVID-19 vaccination programme begins

The NHS has begun the next stage of its vaccine roll-out programme to a further two priority groups today - those aged 70 and...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Popular articles

Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
JCVI updates priority list for COVID-19 vaccine

JCVI updates priority list for COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription